Objectives: The aim of this study was to define the safety and effectiveness of a contrast-enhanced ultrasound (CEUS)-based follow-up as endovascular aortic repair (EVAR) surveillance model at a midterm period of 4 years.
SS30. Vascular Surgery Patients With Coronary Drug-Eluting Stents Have a Significantly Increased Risk of Perioperative MI Despite the Use of Appropriate Antiplatelet Medications
Caron Rockman, Thomas Maldonado, Glenn Jacobowitz, Yu Guo, Neal Cayne, Mikel Sadek, Jeffrey Berger. New York University, New York, NY Objectives: There are no universally accepted guidelines regarding patients who require noncardiac surgery following the placement of drugeluting stents (DES) in the coronary arteries. Delaying elective surgery and maintaining antiplatelet medications have been suggested to reduce the risk of perioperative cardiac complications. The objectives of this study were to evaluate factors predisposing towards perioperative myocardial infarction (MI) in a prospectively studied patient population undergoing open vascular surgery.
Methods: Data were prospectively collected and subsequently analyzed as part of an American Heart Association funded singleinstitution clinical trial designed to analyze factors predisposing towards thrombotic and hemorrhagic complications in patients undergoing open vascular surgery. Perioperative MI was diagnosed by electrocardiogram results, relevant symptoms, and troponin levels using American College of Cardiology/American Heart Association guidelines.
Results: A cohort of 125 patients (30.2% women) who underwent carotid endarterectomy or lower extremity bypass procedures was analyzed; of these, 42.6% had a history of coronary disease, 14.7% had a history of MI, 31% had diabetes, 86.8% had hyperlipidemia, and 91.5% had hypertension. Of the entire cohort, 17 (13.6%) had a prior coronary DES. The incidence of perioperative MI was significantly increased among DES patients compared to those without (23.5% vs 3.7%; P ¼ .01). In contrast, patients with bare metal stents did not have a significantly increased risk of perioperative MI. We examined preoperative medications and the timing of surgery, and none of these factors had a significant effect on the rate of perioperative MI. Of DES patients who sustained a perioperative MI: all had taken aspirin within 24 hours of surgery; 75% had taken clopidogrel within 24 hours of surgery; 75% had taken a statin within 24 hours of surgery; and all were treated with bblockers and an angiotensin-converting enzyme inhibitor. Half (50%) of the perioperative MIs in DES patients occurred after carotid endarterectomy, and 50% occurred following or lower extremity bypass. Half (50%) of the perioperative MIs in DES patients occurred in patients with a remote history of DES (>3 years prior), and 50% occurred in cases in which the DES was placed within 1 year prior to surgery.
Conclusions: Patients with coronary DES remain at significantly increased risk for perioperative MI following open vascular surgery, even several years following DES placement. While appropriate medical management of these patients is imperative, it appears that it does not eliminate the risk of perioperative cardiac complications. An appropriate riskto-benefit analysis must be performed in patients with prior DES who require open vascular surgery procedures to determine the appropriate individual course of treatment.
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